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Association of facial ageing with DNA
methylation and epigenetic age predictions
Riccardo E. Marioni1,2* , Daniel W. Belsky3,4, Ian J. Deary2,5 and Wolfgang Wagner6*
Abstract
Evaluation of biological age, as opposed to chronological age, is of high relevance for interventions to increase
healthy ageing. Highly reproducible age-associated DNA methylation (DNAm) changes can be integrated into
algorithms for epigenetic age predictions. These predictors have mostly been trained to correlate with
chronological age, but they are also indicative for biological ageing. For example, accelerated epigenetic age of
blood is associated with higher risk of all-cause mortality in later life. The perceived age of facial images (face-age)
is also associated with all-cause mortality and other ageing-associated traits. In this study, we therefore tested the
hypothesis that an epigenetic predictor for biological age might be trained on face-age as a surrogate for
biological age rather than on chronological age. Our data demonstrate that facial ageing does not correlate with
either the epigenetic clock or blood-based DNAm measures.
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Main text
We analysed data from the Lothian Birth Cohort 1921
(LBC1921), a longitudinal study of ageing in a 1921 birth
cohort followed up at five assessment waves between
ages 79 and 92 years (Additional file 1) [1]. DNA methy-
lation profiles were analysed in whole blood collected at
mean age 79.1 (SD 0.55) years using Illumina Human-
Methylation450BeadChips as previously described [2].
Perceived facial age (face-age) was assessed from neutral
expression facial photographs taken at mean age
83.3 years (SD 0.52; blood samples were not collected at
this time point) [3]. Briefly, 12 university students (6
male, 6 female) estimated the participants ages based on
high-resolution photographs, taken under the same
lighting conditions, at the same distance, using the same
camera. The images were presented one at a time on a
high-quality cathode ray tube computer monitor.
Face-age acceleration was calculated as the (linear re-
gression) residuals of face-age regressed on chrono-
logical age. Mean estimated face-age was 74.2 years (SD
3.9, range 63.5–85.3). The face-ages that raters assigned
LBC1921 participants based on their photographs
tended to be younger than their true chronological ages
when the photographs were taken. This could reflect
LBC1921 being a relatively healthy and long-lived co-
hort. By the time they were enrolled at age 79 years,
these individuals had outlived their birth cohort’s life ex-
pectancy by more than two decades [4]. Because our
analysis depends on relative differences between esti-
mated facial ages, whether the average face-age tends to
be older or younger than true chronological age will not
affect our results. Overall, DNAm measurements and
face-age assessments were available for 235 individuals
(43% female, 6% current smokers, 49% ever smokers).
Perceived face-age has been linked to mortality risk [5]
and other ageing-associated traits [6]. The relationship
between older face-age and increased mortality risk was
also evident in a previous data release of LBC1921 [3],
and again here using updated survival information (HR
1.39 [1.19, 1.63] per SD increase in face-age, p = 3.5 ×
10− 5; Fig. 1a). People with older face-age also show signs
of accelerated biological ageing as measured from
physiology-based indices (Pearson r ~ 0.2) [7]. Evidence
for association of older face-age with epigenetic ageing is
more sparse; in midlife adults of the Dunedin study,
there was a small effect-size association with one epigen-
etic clock but no association with two others [7]. We
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therefore first tested associations between face-age and
epigenetic age predictors proposed by Horvath (based
on 353 CG dinucleotides - CpGs) [8], and two signatures
that were trained on blood samples by Hannum et al.
(71 CpGs) [9] and Weidner et al. (99 CpGs) [10]. In the
LBC1921 cohort, consisting of older adults, accelerated
epigenetic ageing (residual of epigenetic age regressed
on chronological age) was not associated with higher
face-age (rHorvath:face-age = 0.06, P = 0.35; rHannum:face-age =
0.01, P = 0.93; and rWeidner:face-age = 0.01, P = 0.82).
We then tested the associations between face-age and
DNAm of 307,745 individual CpGs (Additional file 1
and Additional file 2: Table S1). The maximum absolute
Spearman correlation of face-age with DNAm was r =
0.29 (P = 5.1 × 10−6) for cg18402261. To take potential
confounding effects into account, we then performed
epigenome-wide association study (EWAS) analysis with
three nested regression models: the base model (M1;
Additional file 2: Table S2) included covariates for age,
sex, and technical factors (plate, array, position, hybrid-
isation date); additional models added covariates for
smoking history (M2; Additional file 2: Table S3) and
measured white-blood-cell counts (neutrophils, lympho-
cytes, monocytes, eosinophils, and basophils; M3; Add-
itional file 2: Table S4). The lead CpG from the most
conservative model (M3) was cg00871706 (P = 1.8 ×
10−6, chr7:138,666,647, KIAA1549). Pathway analysis of
the closest genes to the top 100 CpGs from this most
conservatively modelled EWAS identified no evidence of
functional enrichment (Bonferroni P > 0.05). Taken to-
gether, the perceived age based on facial photographs re-
vealed no genome-wide significant associations with
DNAm at specific CpG sites or with gene sets linked to
specific biological pathways.
Finally, we tested if a linear combination of CpGs
might provide information about biological ageing. We
conducted LASSO regression analysis on all 307,745
CpGs although this returned only an intercept term and
single CpG site in the predictor (Additional file 1). We
therefore restricted the penalised regression input to the
top 100 CpGs in the M3 EWAS to facial age. The result-
ing algorithm included 32 CpGs (Additional file 2: Table
S5). In the LBC1921 training sample (n = 235, ndeaths =
198), the epigenetic predictor of facial age was correlated
with measured facial age (r = 0.66) and predicted in-
creased risk for mortality (HR 1.31 [1.12, 1.53] per SD
increase in face-age, p = 8.2 × 10−4; Fig. 1b). The associ-
ation with mortality risk was in the same direction but
had a much smaller effect-size and was not statistically
significant in the out-of-sample analysis in the independ-
ent Lothian Birth Cohort 1936 (n = 920, ndeaths = 215;
HR 1.07 [0.94, 1.23], p = 0.32; Additional file 1; Fig. 1c).
This is the first study on epigenome-wide association
of DNAm with perceived facial age. Face-age was clearly
associated with all-cause mortality in the 235 LBC1921
individuals, as previously reported [3]. However, our re-
sults did not support the hypothesis that an epigenetic
measure of biological age could be derived from an ana-
lysis of facial ageing. Efforts to train epigenetic predic-
tors of biological ageing on surrogate biological ageing
measures, such as face-age, may require larger sample
numbers. Precise epigenetic ageing signatures have been
trained to predict chronological age in fewer samples
[10]. The need for more samples to train DNA methyla-
tion algorithms that predict face-age could reflect a
greater degree of measurement error in face-age as a cri-
terion or simply differences in the degree to which DNA
methylation reflects variation in this phenotype. It is also
Fig. 1 Perceived facial ageing is associated with all-cause mortality, but not with DNA methylation signatures trained on perceived ageing. a
Kaplan-Meier plots depict survival rates of LBC1921 participants stratified by the median perceived age in facial images (face-age). b Alternatively,
the participants were stratified by mean age predictions based on an algorithm of 32 CpGs that was trained on face-age of the LBC1921
(DNAmface-age). c The results with this algorithm did not replicate in the independent LBC1936 cohort
Marioni et al. Clinical Epigenetics          (2018) 10:140 Page 2 of 3
possible that the time of blood collection at the age of
79 and 70 (for LBC 1921 and LBC 1936, respectively) is
not ideal for such correlative analysis. In fact, age-related
DNAm changes in peripheral blood occur more rapidly
during childhood and the progression of facial ageing
might differ in younger individuals, too. Longitudinal
data and cohorts with a wide age-range would help to
determine the temporal relationships of face-age and
DNAm. A second limitation is that face-age and DNAm
were measured in the skin and blood, respectively. It is
well known that age-associated modifications occur in
both tissues [8]. But the pace of biological ageing may
vary across different tissues. DNAm analysis in the skin
should therefore be a priority in future face-age analyses;
however, such datasets are not yet available. Similarly,
and to our knowledge, there are no existing, appropri-
ately aged datasets available with data on face-age, DNA
methylation, and survival, which would allow replication
of our findings. Our results indicate that face-age is un-
correlated with both blood-based individual CpG levels
and epigenetic clock estimates, despite face-age itself be-
ing proposed as a measure of biological age.
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